SomaLogic (NASDAQ:SLGC) Stock Price Down 7.2%

SomaLogic Inc (NASDAQ:SLGC) shares traded down 7.2% on Thursday . The stock traded as low as $9.43 and last traded at $9.45. 8,332 shares changed hands during trading, a decline of 99% from the average session volume of 1,355,428 shares. The stock had previously closed at $10.18.

Several equities analysts recently weighed in on the stock. Cowen assumed coverage on shares of SomaLogic in a research report on Tuesday, November 23rd. They set an “outperform” rating and a $18.00 price target for the company. Jefferies Financial Group initiated coverage on shares of SomaLogic in a research report on Friday, December 10th. They set a “buy” rating and a $16.00 target price for the company. Finally, initiated coverage on shares of SomaLogic in a research report on Tuesday, December 14th. They set a “buy” rating and a $19.00 target price for the company.

The firm has a fifty day moving average price of $11.60.

SomaLogic (NASDAQ:SLGC) last announced its quarterly earnings results on Monday, November 15th. The company reported ($0.33) earnings per share (EPS) for the quarter. The firm had revenue of $19.99 million for the quarter. As a group, sell-side analysts expect that SomaLogic Inc will post -0.45 EPS for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the stock. PNC Financial Services Group Inc. purchased a new position in shares of SomaLogic during the third quarter worth approximately $37,000. UBS Group AG bought a new position in shares of SomaLogic in the third quarter worth approximately $58,000. Citadel Advisors LLC bought a new position in shares of SomaLogic in the third quarter worth approximately $129,000. Evolution Wealth Advisors LLC bought a new position in shares of SomaLogic in the third quarter worth approximately $136,000. Finally, Raymond James Financial Services Advisors Inc. bought a new position in shares of SomaLogic in the third quarter worth approximately $203,000. 60.69% of the stock is currently owned by institutional investors and hedge funds.

SomaLogic Company Profile (NASDAQ:SLGC)

SomaLogic Inc provides AI-data driven proteomics technology. SomaLogic Inc, formerly known as CM Life Sciences II Inc, is based in NEW YORK.

Further Reading: What is a blue-chip stock?

Receive News & Ratings for SomaLogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SomaLogic and related companies with MarketBeat.com's FREE daily email newsletter.